Moscatilin from the Orchid Dendrobrium loddigesii Is a Potential Anticancer Agent

  title={Moscatilin from the Orchid Dendrobrium loddigesii Is a Potential Anticancer Agent},
  author={Chi Kuan Ho and Chieh-Chih Chen},
  journal={Cancer Investigation},
  pages={729 - 736}
The Dendrobrium species have been commonly used in traditional Chinese medicine as a tonic to nourish the stomach, replenish body fluid, and reduce fever. However, their application as possible therapeutic agents for the treatment of cancers has not been examined. In this study, we want to examine the efficacy of using moscatilin, a natural antiplatelet agent extracted from the stems of Dendrobrium loddigesii, as an anticancer agent. Our results have shown that moscatilin exerts potent… 
Anticancer Property in Acampe praemorsa and Aerides odorata (Orchidaceae), an In Vitro Approach
The findings from this study showed that the methanolic extract of the A. odorata leaf possesses vast potential as a medicinal drug in breast cancer treatment.
Chemical constituents of Dendrobium cariniferum
Considerable studies have been done on plants of the Dendrobium species (Orchidaceae), which are used as a tonic to nourish stomach, promote secretion of saliva, and reduce fever [1], and which
Dendrobium chrysanthum ethanolic extract induces apoptosis via p53 up-regulation in HeLa cells and inhibits tumor progression in mice
In vivo antitumor activity exhibited significant increase in the life span of DL bearing mice as compared to control with significant decrease in abdominal size along with reduced tumor ascites, demonstrating the anticancer potential of the D. chrysanthum ethanolic extract mediated through p53-dependent apoptosis.
Antitumor Activity of Ethanolic Extract of Dendrobium formosum in T-Cell Lymphoma: An In Vitro and In Vivo Study
The in vivo anticancer activity study illustrates significant increase in the survival time of Dalton's lymphoma bearing mice on treatment with ethanolic extract when compared to control and suggest an alternative in treatment of cancer.
Orchids as Potential Sources of Anticancer Agents: Our Experience
It is demonstrated that orchids which have been used in in various formulations in traditional medicine since ancient times qualify as potential source for novel drug candidates or starting points for further lead optimization towards clinical candidates for the most urgently needed treatment of aggressive types of cancer.
Cytotoxic and anti-metastatic activities of phenolic compounds from Dendrobium ellipsophyllum.
Compounds 4:, 5:, 8: and 10: are responsible for cytotoxic and anti-metastatic activities of D. ellipsophyllum and showed potential apoptosis induction and anoikis-sensitizing effect at non-toxic concentrations.
Phytochemical Profiling and Bioactivities of Pholidota pallida Lindl
Vanda is a well-known anti-inflammatory plant and antiproliferative against various cancer types and orchid derived compounds have been receiving tremendous attention as therapeutics.
Orchids : A review of uses in traditional medicine, its phytochemistry and pharmacology
A comprehensive account of chemical constituents and biological activities of orchids, including alkaloids, bibenzyl derivatives, flavonoids, phenanthrenes and terpenoids which have been isolated recently from this species are presented.


Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.
L86-8275 directly inhibits immunoprecipitated Cdc2 kinase activity from G2/M synchronized MDA-MB-468 breast carcinoma cells and is at least 250-fold more potent than either quercetin or genistein.
Establishment and characteristics of a gastric cancer cell line (HuGC‐OOHIRA) producing high levels of G‐CSF, GM‐CSF, and IL‐6: The presence of autocrine growth control by G‐CSF
This cell line would be very useful for understanding both the cellular and molecular basis for the production of various cytokines such as G‐CSF as well as cytokine‐dependent tumor proliferation.
Antiplatelet aggregation principles of Dendrobium loddigesii.
The MeOH extract of the stem of Dendrobium loddigesii was found to inhibit the aggregation of rabbit platelets induced by arachidonic acid and collagen. Two active compounds, moscatilin [1] and
Effect of suramin on p34cdc2 kinase in vitro and in extracts from human H69 cells: evidence for a double mechanism of action.
Suramin strongly inhibits the catalytic activity of purified p34cdc2 kinase, whereas it only weakly inhibits the p13-agarose precipitated kinase activity from nuclear and cytoplasmic extracts of the asynchronous H69 human small cell lung cancer cells.
Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases.
Immunological analysis of glycolipids on cell surfaces of cultured human tumor cell lines: expression of lactoneotetraosylceramide on tumor cell surfaces.
Findings suggest that nLc4Cer may be a tumor-associated lipid that is detected in cell lines of colonic adenocarcinoma, gastric tumor, and lung tumor and in ascitic fluids of cancer patients.
Activation of programmed cell death by anticancer agents: cisplatin as a model system.
Cisplatin-induced cell death is reminiscent of apoptosis, or programmed cell death, and many other anticancer drugs produce the same phenotypic effects, suggesting that these agents may all interact with the same signal transduction pathway leading to cell death.
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Through its unique selectivity for some cyclin-dependent kinases, roscovitine provides a useful antimitotic reagent for cell cycle studies and may prove interesting to control cells with deregulated cdc2, cdk2 or cdk5 kinase activities.
Induction of plasma protein secretion in a newly established human hepatoma cell line
The establishment of a new human hepatoma cell line, HA22T/VGH, has many of the properties of human hepatocellular carcinoma and provides a good experimental framework to investigate differentiation of human hepatocytes.
Moscatilin, a bibenzyl derivative from the orchid Dendrobium moscatum